Literature DB >> 22991229

Functional 3-D cardiac co-culture model using bioactive chitosan nanofiber scaffolds.

Ali Hussain1, George Collins, Derek Yip, Cheul H Cho.   

Abstract

The in vitro generation of a three-dimensional (3-D) myocardial tissue-like construct employing cells, biomaterials, and biomolecules is a promising strategy in cardiac tissue regeneration, drug testing, and tissue engineering applications. Despite significant progress in this field, current cardiac tissue models are not yet able to stably maintain functional characteristics of cardiomyocytes for long-term culture and therapeutic purposes. The objective of this study was to fabricate bioactive 3-D chitosan nanofiber scaffolds using an electrospinning technique and exploring its potential for long-term cardiac function in the 3-D co-culture model. Chitosan is a natural polysaccharide biomaterial that is biocompatible, biodegradable, non-toxic, and cost effective. Electrospun chitosan was utilized to provide structural scaffolding characterized by scale and architectural resemblance to the extracellular matrix (ECM) in vivo. The chitosan fibers were coated with fibronectin via adsorption in order to enhance cellular adhesion to the fibers and migration into the interfibrous milieu. Ventricular cardiomyocytes were harvested from neonatal rats and studied in various culture conditions (i.e., mono- and co-cultures) for their viability and function. Cellular morphology and functionality were examined using immunofluorescent staining for alpha-sarcomeric actin (SM-actin) and gap junction protein, Connexin-43 (Cx43). Scanning electron microscopy (SEM) and light microscopy were used to investigate cellular morphology, spatial organization, and contractions. Calcium indicator was used to monitor calcium ion flux of beating cardiomyocytes. The results demonstrate that the chitosan nanofibers retained their cylindrical morphology in long-term cell cultures and exhibited good cellular attachment and spreading in the presence of adhesion molecule, fibronectin. Cardiomyocyte mono-cultures resulted in loss of cardiomyocyte polarity and islands of non-coherent contractions. However, the cardiomyocyte-fibroblast co-cultures resulted in polarized cardiomyocyte morphology and retained their morphology and function for long-term culture. The Cx43 expression in the fibroblast co-culture was higher than the cardiomyocytes mono-culture and endothelial cells co-culture. In addition, fibroblast co-cultures demonstrated synchronized contractions involving large tissue-like cellular networks. To our knowledge, this is the first attempt to test chitosan nanofiber scaffolds as a 3-D cardiac co-culture model. Our results demonstrate that chitosan nanofibers can serve as a potential scaffold that can retain cardiac structure and function. These studies will provide useful information to develop a strategy that allows us to generate engineered 3-D cardiac tissue constructs using biocompatible and biodegradable chitosan nanofiber scaffolds for many tissue engineering applications.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22991229     DOI: 10.1002/bit.24727

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  25 in total

1.  Novel in vitro cardiovascular constructs composed of vascular-like networks and cardiomyocytes.

Authors:  Hanna Vuorenpää; Liisa Ikonen; Kirsi Kujala; Outi Huttala; Jertta-Riina Sarkanen; Timo Ylikomi; Katriina Aalto-Setälä; Tuula Heinonen
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-10-26       Impact factor: 2.416

Review 2.  Strategies for improving the physiological relevance of human engineered tissues.

Authors:  Rosalyn D Abbott; David L Kaplan
Journal:  Trends Biotechnol       Date:  2015-04-30       Impact factor: 19.536

3.  Inspiration from heart development: Biomimetic development of functional human cardiac organoids.

Authors:  Dylan J Richards; Robert C Coyle; Yu Tan; Jia Jia; Kerri Wong; Katelynn Toomer; Donald R Menick; Ying Mei
Journal:  Biomaterials       Date:  2017-07-12       Impact factor: 12.479

Review 4.  Tissue Engineering Strategies for Myocardial Regeneration: Acellular Versus Cellular Scaffolds?

Authors:  Maribella Domenech; Lilliana Polo-Corrales; Jaime E Ramirez-Vick; Donald O Freytes
Journal:  Tissue Eng Part B Rev       Date:  2016-07-21       Impact factor: 6.389

Review 5.  Myocyte-fibroblast communication in cardiac fibrosis and arrhythmias: Mechanisms and model systems.

Authors:  Jason Pellman; Jing Zhang; Farah Sheikh
Journal:  J Mol Cell Cardiol       Date:  2016-03-18       Impact factor: 5.000

6.  Thermally responsive nanoparticle-encapsulated curcumin and its combination with mild hyperthermia for enhanced cancer cell destruction.

Authors:  Wei Rao; Wujie Zhang; Izmarie Poventud-Fuentes; Yongchen Wang; Yifeng Lei; Pranay Agarwal; Benjamin Weekes; Chenglong Li; Xiongbin Lu; Jianhua Yu; Xiaoming He
Journal:  Acta Biomater       Date:  2014-02       Impact factor: 8.947

7.  Interpenetrated Si-HPMC/alginate hydrogels as a potential scaffold for human tissue regeneration.

Authors:  Alexia Viguier; Cecile Boyer; Christophe Chassenieux; Lazhar Benyahia; Jérôme Guicheux; Pierre Weiss; Gildas Rethore; Taco Nicolai
Journal:  J Mater Sci Mater Med       Date:  2016-03-29       Impact factor: 3.896

8.  Designing Biomaterial Platforms for Cardiac Tissue and Disease Modeling.

Authors:  Andrew House; Iren Atalla; Eun Jung Lee; Murat Guvendiren
Journal:  Adv Nanobiomed Res       Date:  2020-10-16

9.  A multilayered scaffold for regeneration of smooth muscle and connective tissue layers.

Authors:  Carly M Garrison; Anya Singh-Varma; Alexandra K Pastino; Joseph A M Steele; Joachim Kohn; N Sanjeeva Murthy; Jean E Schwarzbauer
Journal:  J Biomed Mater Res A       Date:  2020-08-14       Impact factor: 4.854

Review 10.  In vivo experience with natural scaffolds for myocardial infarction: the times they are a-changin'.

Authors:  Isaac Perea-Gil; Cristina Prat-Vidal; Antoni Bayes-Genis
Journal:  Stem Cell Res Ther       Date:  2015-12-06       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.